US5422260A
(en)
*
|
1986-05-29 |
1995-06-06 |
Genetics Institute, Inc. -Legal Affairs |
Human factor VIII:c muteins
|
DK0574402T3
(da)
*
|
1990-11-26 |
1998-05-18 |
Chiron Corp |
Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
|
CA2078721A1
(en)
*
|
1991-09-24 |
1993-03-25 |
Hiroshi Yonemura |
Process for preparing human coagulation factor viii protein complex
|
US5364771A
(en)
*
|
1992-04-07 |
1994-11-15 |
Emory University |
Hybrid human/porcine factor VIII
|
US5663060A
(en)
*
|
1992-04-07 |
1997-09-02 |
Emory University |
Hybrid human/animal factor VIII
|
US5888974A
(en)
*
|
1992-04-07 |
1999-03-30 |
Emory University |
Hybrid human/animal factor VIII
|
US5744446A
(en)
*
|
1992-04-07 |
1998-04-28 |
Emory University |
Hybrid human/animal factor VIII
|
US5563045A
(en)
|
1992-11-13 |
1996-10-08 |
Genetics Institute, Inc. |
Chimeric procoagulant proteins
|
AU5602394A
(en)
*
|
1992-11-13 |
1994-06-08 |
Duke University |
Chimeric blood coagulation proteins
|
DE69434689D1
(de)
*
|
1993-06-10 |
2006-05-18 |
Genetic Therapy Inc |
Adenovirale vektoren für die behandlung der hämophilie
|
GB9413035D0
(en)
*
|
1994-06-29 |
1994-08-17 |
Scras |
Antisense oligonucleeotides
|
AU6291896A
(en)
*
|
1995-07-11 |
1997-02-10 |
Chiron Corporation |
Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains
|
ATE319817T1
(de)
*
|
1996-04-24 |
2006-03-15 |
Univ Michigan |
Gegen inaktivierung resistenter faktor viii
|
US8183344B2
(en)
*
|
1996-04-24 |
2012-05-22 |
University Of Michigan |
Inactivation resistant factor VIII
|
US20040092442A1
(en)
*
|
1996-04-24 |
2004-05-13 |
University Of Michigan |
Inactivation resistant factor VIII
|
US7090975B2
(en)
|
1998-03-13 |
2006-08-15 |
Promega Corporation |
Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
|
US6312902B1
(en)
|
1998-03-13 |
2001-11-06 |
Promega Corporation |
Nucleic acid detection
|
US6391551B1
(en)
|
1998-03-13 |
2002-05-21 |
Promega Corporation |
Detection of nucleic acid hybrids
|
US6270973B1
(en)
|
1998-03-13 |
2001-08-07 |
Promega Corporation |
Multiplex method for nucleic acid detection
|
US6235480B1
(en)
|
1998-03-13 |
2001-05-22 |
Promega Corporation |
Detection of nucleic acid hybrids
|
US6270974B1
(en)
|
1998-03-13 |
2001-08-07 |
Promega Corporation |
Exogenous nucleic acid detection
|
US6335162B1
(en)
|
1998-03-13 |
2002-01-01 |
Promega Corporation |
Nucleic acid detection
|
US6268146B1
(en)
|
1998-03-13 |
2001-07-31 |
Promega Corporation |
Analytical methods and materials for nucleic acid detection
|
US6703211B1
(en)
|
1998-03-13 |
2004-03-09 |
Promega Corporation |
Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
US6200560B1
(en)
*
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
AU1598200A
(en)
*
|
1998-10-23 |
2000-05-15 |
Trustees Of The University Of Pennsylvania, The |
Systemic delivery of gene products via skin
|
EP1155150A1
(de)
*
|
1999-02-18 |
2001-11-21 |
Promega Corporation |
Multiplexes verfahren zur nukleinsäureerkennung
|
JP2005518181A
(ja)
*
|
2001-01-12 |
2005-06-23 |
ジ・アメリカン・ナショナル・レッド・クロス |
第viii因子のヘパラン硫酸プロテオグリカン仲介性クリアランスを低下させるための方法および組成物
|
JP2005511038A
(ja)
*
|
2001-11-30 |
2005-04-28 |
エモリー ユニバーシテイ |
第viii因子c2ドメインのバリアント
|
DK2292780T3
(en)
|
2003-09-30 |
2017-12-04 |
Univ Pennsylvania |
Clades and sequences of adeno-associated virus (AAV), vectors containing them, and uses thereof
|
EP1682106A4
(de)
*
|
2003-10-30 |
2008-06-11 |
Univ Emory |
Modifiziertes fviii mit verringerter immunogenität durch mutagenese von a2- und c2-epitopen
|
US7211559B2
(en)
*
|
2003-10-31 |
2007-05-01 |
University Of Maryland, Baltimore |
Factor VIII compositions and methods
|
US20060080848A1
(en)
*
|
2004-10-19 |
2006-04-20 |
Lace Charles R |
Wheel blade sight
|
WO2006110689A2
(en)
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
US20090203077A1
(en)
*
|
2006-06-30 |
2009-08-13 |
The Regents Of The University Of Michigan |
Method of producing factor viii proteins by recombinant methods
|
WO2008005847A2
(en)
|
2006-06-30 |
2008-01-10 |
The Regents Of The University Of Michigan |
Method of producing factor viii proteins by recombinant methods
|
US20120142593A1
(en)
*
|
2009-03-24 |
2012-06-07 |
Bayer Healthcare Llc |
Factor VIII Variants and Methods of Use
|
WO2011028229A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor ix compositions and methods of making and using same
|
CA2782424C
(en)
|
2009-12-06 |
2021-07-27 |
Biogen Idec Hemophilia Inc. |
Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
|
SG183929A1
(en)
|
2010-03-29 |
2012-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
US9611310B2
(en)
|
2010-07-09 |
2017-04-04 |
Bioverativ Therapeutics Inc. |
Systems for factor VIII processing and methods thereof
|
ES2724800T3
(es)
|
2011-02-17 |
2019-09-16 |
Univ Pennsylvania |
Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9
|
US9486507B2
(en)
|
2011-06-10 |
2016-11-08 |
Biogen Ma Inc. |
Pro-coagulant compounds and methods of use thereof
|
WO2013009627A2
(en)
|
2011-07-08 |
2013-01-17 |
Biogen Idec Hemophilia Inc. |
Factor viii chimeric and hybrid polypeptides, and methods of use thereof
|
US10656167B2
(en)
|
2011-07-25 |
2020-05-19 |
Bioverativ Therapeutics Inc. |
Assays to monitor bleeding disorders
|
ES2899848T3
(es)
|
2012-01-12 |
2022-03-15 |
Bioverativ Therapeutics Inc |
Reducción de la inmunogenicidad contra el factor VIII en individuos sometidos a una terapia con factor VIII
|
PT2804623T
(pt)
|
2012-01-12 |
2019-11-18 |
Bioverativ Therapeutics Inc |
Polipéptidos quiméricos do fator viii e suas utilizações
|
CA2864126A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
LT3564260T
(lt)
|
2012-02-15 |
2023-01-10 |
Bioverativ Therapeutics Inc. |
Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
|
EP3404105A1
(de)
|
2012-07-06 |
2018-11-21 |
Bioverativ Therapeutics Inc. |
Einkettige faktor-viii-polypeptide exprimierende zelllinie und verwendungen davon
|
BR112015000267B1
(pt)
|
2012-07-11 |
2023-01-24 |
Bioverativ Therapeutics Inc. |
Proteínas quiméricas, e composição farmacêutica
|
EP2877202A4
(de)
|
2012-07-25 |
2016-06-01 |
Biogen Ma Inc |
Blutfaktorüberwachungstest und verwendungen davon
|
EP2908847B1
(de)
|
2012-10-18 |
2022-03-30 |
Bioverativ Therapeutics Inc. |
Verfahren zur verwendung einer festgelegten dosis eines blutgerinnungsfaktors
|
EP3943102A1
(de)
|
2012-10-30 |
2022-01-26 |
Bioverativ Therapeutics Inc. |
Verfahren zur verwendung von fviii-polypeptid
|
EP2988758B1
(de)
*
|
2013-03-15 |
2018-04-25 |
Bayer HealthCare LLC |
Variante faktor-viii-polypeptide sowie verfahren zu deren herstellung und verwendung
|
UY35462A
(es)
|
2013-03-15 |
2014-10-31 |
Biogen Idec Inc |
Formulación de un polipéptido del factor viii.
|
WO2015012924A2
(en)
|
2013-04-29 |
2015-01-29 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof
|
NZ713904A
(en)
|
2013-06-28 |
2022-02-25 |
Bioverativ Therapeutics Inc |
Thrombin cleavable linker with xten and its uses thereof
|
EP3875106A1
(de)
|
2013-08-08 |
2021-09-08 |
Bioverativ Therapeutics Inc. |
Reinigung von chimären fviii-molekülen
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
EP3065769A4
(de)
|
2013-11-08 |
2017-05-31 |
Biogen MA Inc. |
Prokoagulatorische fusionsverbindung
|
WO2015085276A1
(en)
|
2013-12-06 |
2015-06-11 |
Biogen Idec Ma Inc. |
Population pharmacokinetics tools and uses thereof
|
CN116621991A
(zh)
|
2014-01-10 |
2023-08-22 |
比奥贝拉蒂治疗公司 |
因子viii嵌合蛋白及其用途
|
WO2016168728A2
(en)
|
2015-04-16 |
2016-10-20 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
EA201890423A1
(ru)
|
2015-08-03 |
2018-07-31 |
Биовератив Терапьютикс Инк. |
Слитые белки фактора ix, способы их получения и применения
|
SG11202010767SA
(en)
|
2018-05-18 |
2020-11-27 |
Bioverativ Therapeutics Inc |
Methods of treating hemophilia a
|
JP2023537070A
(ja)
|
2020-08-07 |
2023-08-30 |
アミカス セラピューティックス インコーポレイテッド |
小胞を標的とするタンパク質及びその使用
|
WO2024168358A1
(en)
|
2023-02-10 |
2024-08-15 |
Expression Therapeutics, Llc |
Lentiviral system
|